P
Peter J. Barnes
Researcher at National Institutes of Health
Publications - 1554
Citations - 177909
Peter J. Barnes is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 194, co-authored 1530 publications receiving 166618 citations. Previous affiliations of Peter J. Barnes include University of Nebraska Medical Center & Novartis.
Papers
More filters
Journal ArticleDOI
Review of exhaled nitric oxide in chronic obstructive pulmonary disease
Arthur F. Gelb,Peter J. Barnes,Steven C. George,Fabio Luigi Massimo Ricciardolo,Giussepe DiMaria,Noe Zamel +5 more
TL;DR: Routine serial measurements of F(E)NO for clinical asthma management does not appear warranted and the role of add-on monitoring of exhaled NO to GOLD management guidelines is less clear because of the absence of conclusive doubleblind, randomized, control trial studies concerning potential clinical benefits in the management of COPD.
Reference BookDOI
Neuropeptides in respiratory medicine
TL;DR: Part 1 Innervation of the Airways: Neuropeptides and Classic Innervation - Neural Structures in Human Airways Functional Autonomic Innervation in the Airways - The Cholinergic and Adrenergic Systems NeuropePTides in the Lower Airways Investigated by Modem Microscopy Neural Control of the Upper Respiratory Tract Peptide Biosynthesis and Secretion.
Journal ArticleDOI
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou,Dimitris Veroutis,Koralia E. Paschalaki,Periklis G. Foukas,Nefeli Lagopati,Marios Dimitriou,Angelos Papaspyropoulos,Bindu Konda,O Hazapis,Aikaterini Polyzou,Sophia Havaki,Athanassios Kotsinas,Christos Kittas,Athanasios G. Tzioufas,Laurence de Leval,Demetris Vassilakos,Sotirios Tsiodras,Barry R. Stripp,Argyris Papantonis,Giovanni Blandino,Ioannis Karakasiliotis,Peter J. Barnes,Vassilis G. Gorgoulis +22 more
TL;DR: In this paper , the authors investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with cellular senescence and SASP, and they demonstrated that in severe COVID-19, alveolar type 2 (AT2) cells infected by SARS-coV2 exhibit a proinflammatory phenotype.
Journal ArticleDOI
Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
TL;DR: The inability of drugs which increase tissue cyclic GMP content and exhibit anti‐spasmogenic activity to inhibit methacholine‐stimulated Ins(1,4,5)P3 formation suggests that, unlike vascular smooth muscle, cyclicGMP‐dependent mechanisms do not regulate receptor‐mediated phosphoinositide hydrolysis in BTSM.
Book ChapterDOI
Potential novel therapies for chronic obstructive pulmonary disease.
TL;DR: The inflammatory response in COPD is essentially steroid-resistant so that alternative anti-inflammatory treatments are needed and new therapeutic approaches to prevent disease progression are urgently needed.